Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |